Despite the high incidence of Hidradenitis Suppurativa (HS) and impact on quality of life, there is a shortage of specific targeted therapies for HS due to poor understanding of the underlying complex pathological mechanisms.

Associate Professor Erin McMeniman (Dermatologist, Metro South Health) and Dr Snehlata Kumari (Group Leader/Senior Research Fellow, The University of Queensland Diamantina Institute) are conducting research to better understand the HS disease mechanism, elucidating predictive therapeutic biomarkers for early detection/intervention and potentially identifying direct novel therapeutic targets. The team has recently received a collaborative grant from the Metro South Health and the Translational Research Institute (TRI) - "Leading Innovations through New Collaborations (LINC)".

Project members

Associate Professor Erin McMeniman

ATH - Associate Professor
Princess Alexandra Hospital Southside Clinical Unit
Principal Research Fellow
Frazer Institute